Seeing Is Believing
Healthcare - Sector
PTGX is currently covered by 7 analysts with an average price target of $104.96. This is a potential upside of $15.31 (17.08%) from yesterday's end of day stock price of $89.65.
Protagonist Therapeutics's activity chart (see below) currently has 130 price targets and 124 ratings on display. The stock rating distribution of PTGX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 93.21% with an average time for these price targets to be met of 536.94 days.
Highest price target for PTGX is $102, Lowest price target is $80, average price target is $86.71.
Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 07-Nov-2025. First documented stock forecast 06-Sep-2016.
Currently out of the existing stock ratings of PTGX, 28 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$102
$12 (13.33%)
$69
29 days ago
(07-Nov-2025)
13/14 (92.86%)
$22.22 (27.85%)
163
Buy
$88
$-2 (-2.22%)
$72
29 days ago
(07-Nov-2025)
4/4 (100%)
$8.22 (10.30%)
135
Buy
$81
$-9 (-10.00%)
$57
29 days ago
(07-Nov-2025)
6/6 (100%)
$1.22 (1.53%)
89
Buy
$82
$-8 (-8.89%)
$73
1 months 8 days ago
(28-Oct-2025)
7/7 (100%)
$3.49 (4.45%)
451
Buy
$88
$-2 (-2.22%)
$76
1 months 8 days ago
(28-Oct-2025)
3/3 (100%)
$9.49 (12.09%)
198
What is PTGX (Protagonist Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PTGX (Protagonist Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PTGX (Protagonist Therapeutics)?
Which analyst is the currently most bullish on PTGX (Protagonist Therapeutics)?
Which analyst is the currently most reserved on PTGX (Protagonist Therapeutics)?